Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition

SARS-CoV-2 infection continues to cause increased morbidity and mortality, and due to the slow pace of vaccination COVID-19 will probably remain a global burden to health systems for a long time. Unfortunately, the necessary prevention and treatment strategies of COVID-19 have led to restriction mea...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuorio, Alpo, Strandberg, Timo E., Raal, Frederik, Santos, Raul D., Kovanen, Petri T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349422/
https://www.ncbi.nlm.nih.gov/pubmed/34622243
http://dx.doi.org/10.1016/j.athplu.2021.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349422/
https://www.ncbi.nlm.nih.gov/pubmed/34622243
http://dx.doi.org/10.1016/j.athplu.2021.08.001

Ejemplares similares